Astera Labs, Inc. (NASDAQ:ALAB) Receives $325.25 Consensus Price Target from Analysts

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-three analysts that are currently covering the stock, Marketbeat Ratings reports. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $333.00.

A number of brokerages recently issued reports on ALAB. Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Susquehanna boosted their price target on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Jefferies Financial Group increased their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Evercore restated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Finally, Royal Bank Of Canada lifted their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th.

Check Out Our Latest Report on ALAB

Astera Labs Price Performance

ALAB stock opened at $320.17 on Thursday. The business’s 50-day moving average is $357.48 and its two-hundred day moving average is $241.79. The firm has a market capitalization of $55.55 billion, a P/E ratio of 158.50 and a beta of 3.84. Astera Labs has a 1 year low of $97.89 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same period in the previous year, the company posted $0.44 earnings per share. The business’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts expect that Astera Labs will post 2.7 EPS for the current year.

Insiders Place Their Bets

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $3,276,963.90. Following the sale, the director directly owned 5,292 shares in the company, valued at $1,928,140.20. This trade represents a 62.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 631,979 shares of company stock worth $215,479,247. 10.40% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs during the second quarter worth approximately $25,000. Transamerica Financial Advisors LLC purchased a new position in Astera Labs in the second quarter valued at approximately $35,000. Johnson Financial Group Inc. purchased a new position in Astera Labs in the second quarter valued at approximately $43,000. Bell Investment Advisors Inc acquired a new stake in Astera Labs during the second quarter worth approximately $43,000. Finally, Reflection Asset Management acquired a new stake in Astera Labs during the fourth quarter worth approximately $25,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.